Vidal, Joana
Hospital Del Mar · Centro de Investigación Biomédica en Red de Cáncer
3 papers on CoChatORCID 0000-0002-2560-1203
Most cited papers
- Verified
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
Van Emburgh, B. O., Arena, S., Siravegna, G., Lazzari, L., Crisafulli, G., Corti, G., Mussolin, B., Baldi, F., Buscarino, M., Bartolini, A., et al. (2016) · Nature Communications
Colorectal Cancer Treatments and StudiesLung Cancer Treatments and Mutations
Cited by 214
- Verified
Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial
Montagut, C., Argilés, G., Ciardiello, F., Poulsen, T. T., Dienstmann, R., Kragh, M., Kopetz, S., Lindsted, T., Ding, C., Vidal, J., et al. (2018) · JAMA Oncology
Colorectal Cancer Treatments and StudiesLung Cancer Treatments and Mutations
Cited by 135
- Verified
The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer
Sánchez-Martín, F. J., Bellosillo, B., Gelabert-Baldrich, M., Dalmases, A., Cañadas, I., Vidal, J., Martinez, A., Argilés, G., Siravegna, G., Arena, S., et al. (2016) · Clinical Cancer Research
Colorectal Cancer Treatments and StudiesHER2/EGFR in Cancer Research
Cited by 68
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free